A Single-Blind, Randomized, Placebo Controlled Study to Evaluate the Benefits and Safety of Endourage Targeted Wellness Formula C Sublingual +Drops in People with Post-Acute Coronavirus Disease 2019 Syndrome-Reference-Cited by-同舟云学术

A Single-Blind, Randomized, Placebo Controlled Study to Evaluate the Benefits and Safety of Endourage Targeted Wellness Formula C Sublingual +Drops in People with Post-Acute Coronavirus Disease 2019 Syndrome

Published:2022-10-14 Issue: Volume: Page:
ISSN:2578-5125
Container-title:Cannabis and Cannabinoid Research
language:en
Short-container-title:Cannabis and Cannabinoid Research

Author:

Young Thomas P.¹^ORCID,Erickson Joel S.¹,Hattan Shannon L.¹,Guzy Serge²,Hershkowitz Fabienne²,Steward Michael D.³

Affiliation:

1. Joel S Erickson, MD+Thomas P Young, PhD, NP, Inc., Novato, California, USA.

2. ProPharma, Inc., Hillsborough, New Jersey, USA.

3. Endourage, LLC, Wheatridge, Colorado, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Complementary and alternative medicine,Pharmacology

Link

https://www.liebertpub.com/doi/pdf/10.1089/can.2022.0135

Reference19 articles.

1. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines

2. Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea

3. Cannabidiol for Viral Diseases: Hype or Hope?

4. Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa

5. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possible Role of Cannabis in the Management of Neuroinflammation in Patients with Post-COVID Condition;International Journal of Molecular Sciences;2024-03-29

2. Cannabis-based medicinal products (CBMPs) for the treatment of Long COVID symptoms: current and potential applications;Exploration of Medicine;2023-08-31

3. Long COVID and possible preventive options;Inflammopharmacology;2023-06-21

4. Antiviral activities of hemp cannabinoids;Clinical Science;2023-04